Antitumor Activities of Interleukin-12 in Melanoma

被引:16
|
作者
Gao, Wei [1 ]
Pan, Jun [2 ]
Pan, Jianping [1 ]
机构
[1] Zhejiang Univ City Coll, Inst Translat Med, Hangzhou 310015, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Inst Canc, Sch Med, Hangzhou 310009, Peoples R China
基金
中国国家自然科学基金;
关键词
melanoma; IL-12; cancer therapy; T-CELLS; CANCER-IMMUNOTHERAPY; GENE ELECTROTRANSFER; IMMUNE-RESPONSES; IL-12; DELIVERY; THERAPY; ELECTROCHEMOTHERAPY; ELECTROPORATION; DIFFERENTIATION;
D O I
10.3390/cancers14225592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Immunotherapy has been evolving rapidly in recent years. As a key component of the immune system, cytokines play essential roles not only in immune regulation but also in anti-tumor immunity. In the present review, we summarized the basic biological activities of IL-12 and its application in clinical trials for the therapy of melanoma. We also discussed the combined therapy of IL-12 with immune checkpoint inhibitors, cytokines and other therapeutic drugs in preclinical and clinical studies. The immune-related side effects of IL-12 and promising technological approaches that improve the efficacy and safety of IL-12 or IL-12 encoding vectors in the treatment of melanoma are also discussed. Melanoma is the most common and serious malignant tumor among skin cancers. Although more and more studies have revolutionized the systematic treatment of advanced melanoma in recent years, access to innovative drugs for melanoma is still greatly restricted in many countries. IL-12 produced mainly by antigen-presenting cells regulates the immune response and affects the differentiation of T cells in the process of antigen presentation. However, the dose-limited toxicity of IL-12 limits its clinical application. The present review summarizes the basic biological functions and toxicity of IL-12 in the treatment of melanoma and discusses the clinical application of IL-12, especially the combination of IL-12 with immune checkpoint inhibitors, cytokines and other therapeutic drugs. We also summarize several promising technological approaches such as carriers that have been developed to improve the pharmacokinetics, efficacy and safety of IL-12 or IL-12 encoding plasmid application.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] ANTITUMOR-ACTIVITY OF INTERLEUKIN-12
    BRUNDA, MJ
    GATELY, MK
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 71 (03): : 253 - 255
  • [2] Antitumor and antimetastatic activity of interleukin-12
    Hendrzak, JA
    Brunda, MJ
    ATTEMPTS TO UNDERSTAND METASTASIS FORMATION III: THERAPEUTIC APPROACHES FOR METASTASIS TREATMENT, 1996, 213 : 65 - 83
  • [3] Antitumor activities in vivo of Interleukin-12 gene modified dendritic cells in murine models
    刘彬彬
    叶胜龙
    贺平
    薛琼
    高冬梅
    汤钊猷
    中华肝脏病杂志, 2000, (06) : 350 - 351
  • [4] Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18
    Nagai, H
    Hara, I
    Horikawa, T
    Fujii, M
    Kurimoto, M
    Kamidono, S
    Ichihashi, M
    CANCER INVESTIGATION, 2000, 18 (03) : 206 - 213
  • [5] Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18.
    Nagai, H
    Horikawa, T
    Hara, I
    Ichihashi, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 650 - 650
  • [6] AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine
    Yin, Xiaoling
    Yan, Xuexian
    Yang, Qinan
    Cao, Hui
    Liang, Houjie
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (03) : 263 - 268
  • [7] Interleukin-12: Murine models of a potent antitumor agent
    Brunda, MJ
    Luistro, L
    Rumennik, L
    Wright, RB
    Wigginton, JM
    Wiltrout, RH
    Hendrzak, JA
    Palleroni, AV
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 266 - 274
  • [8] Interleukin-12: Functional activities and implications for disease
    Zundler, Sebastian
    Neurath, Markus F.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (05) : 559 - 568
  • [9] Therapy of melanoma with interleukin-12 and interferon-alpha.
    Carson, W
    Anghelina, M
    Dierksheide, J
    Dierksheide, S
    Sundaram, P
    Triozzi, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S7 - S7
  • [10] Evaluation of the antitumor activity of the interleukin-12 pulse interleukin-2 combination
    Wigginton, JM
    Komschlies, KL
    Green, JE
    Cox, GW
    Jorcyk, CL
    Back, TC
    Franco, JL
    Brunda, MJ
    Wiltrout, RH
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 434 - 439